Beta-interferon and glatiramer acetate were effective for the treatment of multiple sclerosis, with cost-effectiveness ranging from £7000 to £34,000 per quality-adjusted life-year.
http://ift.tt/2xpWfMn
Πέμπτη 21 Σεπτεμβρίου 2017
Clinical effectiveness and cost-effectiveness of beta-interferon and glatiramer acetate for treating multiple sclerosis: systematic review and economic evaluation.
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
http://bit.ly/2SylJiJ
-
Publication date: Available online 22 March 2017 Source: Medical Journal Armed Forces India Author(s): S.C. Shaw, M.S. Vinod, Amit Devgan ...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου